Enzo Biochem Inc (ENZB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.4899 +0.0090 (+1.87%) 04/29/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.4899 unch (unch) 15:04 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ENZB | CLGN | LGVN | ||
| Company | Enzo Biochem Inc | Collplant Biotechnologies Ltd ADR | Longeveron Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.4750 | 2.21 | 1.6400 | ||
| High | 0.4899 | 2.53 | 1.6550 | ||
| Low | 0.4601 | 2.19 | 1.5700 | ||
| Last | 0.4899 | 2.21 | 1.6000 | ||
| Change | +0.0090 | unch | -0.0500 | ||
| % Change | +1.87% | +0.23% | -3.03% | ||
| Volume | 41,886 | 32,288 | 44,002 | ||
| 20-Day Average Volume | 741,089 | 12,914 | 113,435 | ||
| Previous Close | 0.4809 | 2.21 | 1.6500 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.3656 | 2.37 | 1.4913 | ||
| 20-Day Raw Stochastic | 79.83% | 34.13% | 63.49% | ||
| 20-Day Relative Strength | 56.25% | 33.09% | 51.66% | ||
| Weighted Alpha | -60.47 | -66.50 | -70.21 | ||
| Today's Opinion | 56% Sell | 100% Sell | 56% Sell | ||
| Previous Opinion | 56% Sell | 100% Sell | 56% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +24.03% since 04/22/25 | -0.23% since 04/22/25 | +2.56% since 04/22/25 | ||
| Low | 0.3800 on 04/23/25 | 2.00 on 04/23/25 | 1.5400 on 04/23/25 | ||
| High | 0.4900 on 04/24/25 | 2.58 on 04/23/25 | 1.8300 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +13.59% since 03/28/25 | -13.14% since 03/28/25 | +1.27% since 03/28/25 | ||
| Low | 0.2520 on 04/04/25 | 2.00 on 04/23/25 | 1.2000 on 04/09/25 | ||
| High | 0.5500 on 04/22/25 | 2.91 on 03/31/25 | 1.8300 on 04/28/25 | ||
| 3-Month | |||||
| %Chg | -22.30% since 01/29/25 | -42.47% since 01/29/25 | +3.90% since 01/29/25 | ||
| Low | 0.2520 on 04/04/25 | 2.00 on 04/23/25 | 1.2000 on 04/09/25 | ||
| High | 0.6302 on 01/30/25 | 4.00 on 02/04/25 | 1.9198 on 03/24/25 | ||
| 6-Month | |||||
| %Chg | -56.65% since 10/29/24 | -43.49% since 10/29/24 | -26.94% since 10/29/24 | ||
| Low | 0.2520 on 04/04/25 | 2.00 on 04/23/25 | 1.2000 on 04/09/25 | ||
| High | 1.1900 on 10/30/24 | 4.58 on 11/12/24 | 2.3100 on 11/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 25,201 | 25,316 | 24,631 | ||
| Shares Outstanding, K | 52,403 | 11,455 | 14,928 | ||
| Annual Sales | 31,910,000 | 520,000 | 2,390,000 | ||
| Annual Net Income | -26,080,000 | -16,610,000 | -15,970,000 | ||
| Last Quarter Sales | 7,330,000 | 160,000 | 600,000 | ||
| Last Quarter Net Income | -1,540,000 | -3,880,000 | -4,080,000 | ||
| 60-Month Beta | 1.19 | 1.32 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 03/17/25 | -0.34 on 03/26/25 | -0.34 on 11/12/24 | ||
| Latest Earnings Date | 06/12/25 | 06/04/25 | 05/13/25 | ||
| Most Recent Dividend | 0.100 on 11/15/24 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||